Skip to main content
Erschienen in: Clinical Research in Cardiology 4/2012

01.04.2012 | Original Paper

Polymorphisms of miRNAs genes are associated with the risk and prognosis of coronary artery disease

verfasst von: Hong Zhi, Lina Wang, Genshan Ma, Xingzhou Ye, Xiaojin Yu, Yi Zhu, Yu Zhang, Jiaju Zhang, Bei Wang

Erschienen in: Clinical Research in Cardiology | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

MicroRNAs (miRNAs) are small, single-stranded, non-protein-coding RNAs of about 22 nucleotides. miRNA molecules have been identified that plays key roles in a broad range of physiologic and pathologic processes. Polymorphisms in the corresponding sequence space are likely to make a significant contribution to phenotypic variation.

Methods and results

To assess the variations of rs11614913 T → C in hsa-mir-196a2 and rs3746444 A → G in hsa-mir-499 in the complex etiology of coronary artery disease (CAD), 956 CAD patients diagnosed by coronary arterial angiography and 620 controls were enrolled. Among the patients, 785 (785/956) had complete follow-ups for 42 months. The variant genotypes CC/CT of hsa-mir-196a2 rs11614913 T → C were not associated with a significantly increased risk of CAD (adjusted OR = 1.02, 95% CI = 0.76–1.38), compared with wide genotype TT, but CC and CC/CT genotypes were associated with 34 and 35% increased risks of serious prognosis of CAD (adjusted HR = 1.34, 95% CI = 1.02–1.75 for CC; adjusted HR = 1.35, 95% CI = 1.03–1.75 for CC/CT). In the variant of hsa-mir-499 rs3746444A → G, GG was associated with the 223% increased risk of CAD (adjusted OR = 3.23, 95% CI = 1.56–6.67). Cox regression analysis showed that age, smoking status, numbers of pathological changes in coronary arteries, rs11614913 T → C, and diabetes mellitus were associated with serious prognosis of CAD.

Conclusion

Our findings strongly implicate the functional miRNAs polymorphisms of hsa-mir-196a2 and hsa-mir-499 genes may modulate the occurrence or prognosis in Chinese CAD.
Literatur
2.
Zurück zum Zitat Mirzaei M, Truswell AS, Taylor R, Leeder SR (2009) Coronary heart disease epidemics: not all the same. Heart 95:740–746PubMedCrossRef Mirzaei M, Truswell AS, Taylor R, Leeder SR (2009) Coronary heart disease epidemics: not all the same. Heart 95:740–746PubMedCrossRef
3.
Zurück zum Zitat Oppenheimer GM (2010) Framingham heart study: the first 20 years. Prog Cardiovasc Dis 53:55–61PubMedCrossRef Oppenheimer GM (2010) Framingham heart study: the first 20 years. Prog Cardiovasc Dis 53:55–61PubMedCrossRef
4.
Zurück zum Zitat Sullivan PW, Ghushchyan V, Wyatt HR, Wu EQ, Hill JO (2007) Impact of cardiometabolic risk factor clusters on health-related quality of life in the U.S. Obesity 15:511–521PubMedCrossRef Sullivan PW, Ghushchyan V, Wyatt HR, Wu EQ, Hill JO (2007) Impact of cardiometabolic risk factor clusters on health-related quality of life in the U.S. Obesity 15:511–521PubMedCrossRef
5.
Zurück zum Zitat May A, Wang TJ (2008) Biomarkers for cardiovascular disease: challenges and future directions. Trends Mol Med 14:261–267PubMedCrossRef May A, Wang TJ (2008) Biomarkers for cardiovascular disease: challenges and future directions. Trends Mol Med 14:261–267PubMedCrossRef
6.
Zurück zum Zitat Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O et al (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37:766–770PubMedCrossRef Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O et al (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37:766–770PubMedCrossRef
7.
Zurück zum Zitat Negrini M, Nicoloso MS, Calin GA (2009) MicroRNAs and cancer—new paradigms in molecular oncology. Curr Opin Cell Biol 21:470–479PubMedCrossRef Negrini M, Nicoloso MS, Calin GA (2009) MicroRNAs and cancer—new paradigms in molecular oncology. Curr Opin Cell Biol 21:470–479PubMedCrossRef
8.
Zurück zum Zitat Divakaran V, Mann DL (2008) The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res 103:1072–1083PubMedCrossRef Divakaran V, Mann DL (2008) The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res 103:1072–1083PubMedCrossRef
9.
Zurück zum Zitat Cai B, Pan Z, Lu Y (2010) The roles of microRNAs in heart diseases: a novel important regulator. Curr Med Chem 17:407–411PubMedCrossRef Cai B, Pan Z, Lu Y (2010) The roles of microRNAs in heart diseases: a novel important regulator. Curr Med Chem 17:407–411PubMedCrossRef
10.
Zurück zum Zitat Small EM, Frost RJ, Olson EN (2010) MicroRNAs add a new dimension to cardiovascular disease. Circulation 121:1022–1032PubMedCrossRef Small EM, Frost RJ, Olson EN (2010) MicroRNAs add a new dimension to cardiovascular disease. Circulation 121:1022–1032PubMedCrossRef
11.
Zurück zum Zitat Huang ZP, Neppl RL, Wang DZ (2010) MicroRNAs in cardiac remodeling and disease. J Cardiovasc Transl Res 3:212–218PubMedCrossRef Huang ZP, Neppl RL, Wang DZ (2010) MicroRNAs in cardiac remodeling and disease. J Cardiovasc Transl Res 3:212–218PubMedCrossRef
12.
Zurück zum Zitat D′Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG et al (2010) Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 31:2765–2773PubMedCrossRef D′Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG et al (2010) Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 31:2765–2773PubMedCrossRef
13.
Zurück zum Zitat Georges M, Coppieters W, Charlier C (2007) Polymorphic miRNA-mediated gene regulation: contribution to phenotypic variation and disease. Curr Opin Genet Dev 17:166–176PubMedCrossRef Georges M, Coppieters W, Charlier C (2007) Polymorphic miRNA-mediated gene regulation: contribution to phenotypic variation and disease. Curr Opin Genet Dev 17:166–176PubMedCrossRef
14.
15.
Zurück zum Zitat Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L et al (2008) Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 118:2600–2608PubMedCrossRef Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L et al (2008) Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 118:2600–2608PubMedCrossRef
16.
Zurück zum Zitat Beetz C, Schüle R, Deconinck T, Tran-Viet KN, Zhu H, Kremer BP et al (2008) REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31. Brain 131:1078–1086PubMedCrossRef Beetz C, Schüle R, Deconinck T, Tran-Viet KN, Zhu H, Kremer BP et al (2008) REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31. Brain 131:1078–1086PubMedCrossRef
17.
Zurück zum Zitat Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibé B et al (2006) A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 38:813–818PubMedCrossRef Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibé B et al (2006) A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 38:813–818PubMedCrossRef
18.
Zurück zum Zitat Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS et al (2007) Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 81:405–413PubMedCrossRef Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS et al (2007) Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 81:405–413PubMedCrossRef
19.
Zurück zum Zitat Lv K, Guo Y, Zhang Y, Wang K, Jia Y, Sun S (2008) Allele-specific targeting of hsa-miR-657 to human IGF2R creates a potential mechanism underlying the association of ACAA-insertion/deletion polymorphism with Type 2 diabetes. Biochem Biophys Res Commun 374:101–105PubMedCrossRef Lv K, Guo Y, Zhang Y, Wang K, Jia Y, Sun S (2008) Allele-specific targeting of hsa-miR-657 to human IGF2R creates a potential mechanism underlying the association of ACAA-insertion/deletion polymorphism with Type 2 diabetes. Biochem Biophys Res Commun 374:101–105PubMedCrossRef
20.
Zurück zum Zitat Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J et al (2008) Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 30:79–84CrossRef Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J et al (2008) Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 30:79–84CrossRef
21.
Zurück zum Zitat Tian T, Shu Y, Chen J, Hu Z, Xu L, Jin G et al (2009) A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomark Prev 18:1183–1187CrossRef Tian T, Shu Y, Chen J, Hu Z, Xu L, Jin G et al (2009) A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomark Prev 18:1183–1187CrossRef
22.
Zurück zum Zitat Gao LB, Bai P, Pan XM, Jia J, Li LJ, Liang WB et al (2011) The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 125:571–574PubMedCrossRef Gao LB, Bai P, Pan XM, Jia J, Li LJ, Liang WB et al (2011) The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 125:571–574PubMedCrossRef
23.
Zurück zum Zitat Xu J, Hu Z, Xu Z, Gu H, Yi L, Cao H et al (2009) Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population. Hum Mutat 30:1231–1236PubMedCrossRef Xu J, Hu Z, Xu Z, Gu H, Yi L, Cao H et al (2009) Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population. Hum Mutat 30:1231–1236PubMedCrossRef
24.
Zurück zum Zitat Zhou B, Rao L, Peng Y, Wang Y, Chen Y, Song Y et al (2010) Common genetic polymorphisms in pre-microRNAs were associated with increased risk of dilated cardiomyopathy. Clin Chim Acta 411:1287–1290PubMedCrossRef Zhou B, Rao L, Peng Y, Wang Y, Chen Y, Song Y et al (2010) Common genetic polymorphisms in pre-microRNAs were associated with increased risk of dilated cardiomyopathy. Clin Chim Acta 411:1287–1290PubMedCrossRef
25.
Zurück zum Zitat Catalucci D, Gallo P, Condorelli G (2009) MicroRNAs in cardiovascular biology and heart disease. Circ Cardiovasc Genet 2:402–408PubMedCrossRef Catalucci D, Gallo P, Condorelli G (2009) MicroRNAs in cardiovascular biology and heart disease. Circ Cardiovasc Genet 2:402–408PubMedCrossRef
26.
Zurück zum Zitat Lukiw WJ (2007) Micro-RNA speciation in fetal, adult and Alzheimer’s disease hippocampus. Neuroreport 18:297–300PubMedCrossRef Lukiw WJ (2007) Micro-RNA speciation in fetal, adult and Alzheimer’s disease hippocampus. Neuroreport 18:297–300PubMedCrossRef
27.
Zurück zum Zitat Krutovskikh VA, Herceg Z (2010) Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers. Bioessays 32:894–904PubMedCrossRef Krutovskikh VA, Herceg Z (2010) Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers. Bioessays 32:894–904PubMedCrossRef
28.
Zurück zum Zitat Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al (2005) MicroRNA expression profiles classify human cancers. Nature 435:834–838PubMedCrossRef Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al (2005) MicroRNA expression profiles classify human cancers. Nature 435:834–838PubMedCrossRef
29.
Zurück zum Zitat Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y et al (2010) Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 28:1721–1726PubMedCrossRef Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y et al (2010) Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 28:1721–1726PubMedCrossRef
30.
Zurück zum Zitat Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A et al (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129:1401–1414PubMedCrossRef Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A et al (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129:1401–1414PubMedCrossRef
31.
Zurück zum Zitat Liu Z, Li G, Wei S, Niu J, El-Naggar AK, Sturgis EM et al (2010) Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 116:4753–4760PubMedCrossRef Liu Z, Li G, Wei S, Niu J, El-Naggar AK, Sturgis EM et al (2010) Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 116:4753–4760PubMedCrossRef
32.
Zurück zum Zitat Yang H, Dinney CP, Ye Y, Zhu Y, Grossman HB, Wu X (2008) Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res 68:2530–2537PubMedCrossRef Yang H, Dinney CP, Ye Y, Zhu Y, Grossman HB, Wu X (2008) Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res 68:2530–2537PubMedCrossRef
33.
Zurück zum Zitat Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, Gu J et al (2008) Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res 14:7956–7962PubMedCrossRef Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, Gu J et al (2008) Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res 14:7956–7962PubMedCrossRef
34.
Zurück zum Zitat Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG et al (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297:1901–1908PubMedCrossRef Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG et al (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297:1901–1908PubMedCrossRef
35.
Zurück zum Zitat Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setién F (2007) Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 67:1424–1429PubMedCrossRef Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setién F (2007) Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 67:1424–1429PubMedCrossRef
36.
Zurück zum Zitat Duan R, Pak C, Jin P (2007) Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 16:1124–1131PubMedCrossRef Duan R, Pak C, Jin P (2007) Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 16:1124–1131PubMedCrossRef
Metadaten
Titel
Polymorphisms of miRNAs genes are associated with the risk and prognosis of coronary artery disease
verfasst von
Hong Zhi
Lina Wang
Genshan Ma
Xingzhou Ye
Xiaojin Yu
Yi Zhu
Yu Zhang
Jiaju Zhang
Bei Wang
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
Clinical Research in Cardiology / Ausgabe 4/2012
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-011-0391-3

Weitere Artikel der Ausgabe 4/2012

Clinical Research in Cardiology 4/2012 Zur Ausgabe

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

02.05.2024 Ablationstherapie Nachrichten

Ob die Katheterablation von Vorhofflimmern bei Patienten mit Herzinsuffizienz die Komplikationsraten senkt, scheint davon abzuhängen, ob die Auswurfleistung erhalten ist oder nicht. Das legen die Ergebnisse einer Metaanalyse nahe.

Weniger Extremitätenischämien mit dualer Plättchenhemmung

02.05.2024 Thrombozytenaggregationshemmer Nachrichten

Eine Behandlung mit Ticagrelor zusätzlich zu ASS kann das Risiko für Revaskularisierungen und Amputationen von Extremitäten bei Diabetikern mit stabiler KHK deutlich reduzieren, vor allem für solche mit PAVK. Dafür spricht eine Auswertung der Interventionsstudie THEMIS.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.